NLRP3 and Hyperglycemia: In THP‐1 cells, PKM2 activators TEPP‐46 and glycolysis inhibitor 2‐DG could reverse the protein increase of NLRP3, IL‐18 and IL1‐β induced by hyperglycemia.105